Diabetes medication recalled for potentially carcinogenic substance

Local companies have voluntarily recalled a total of 20 million extended-release tablets of metformin, a prescribed drug for diabetes, since Taiwan's Food and Drug Administration (FDA) asked suppliers of the medication to examine their products for the potential cancer-causing n-nitrosodimethylamine (NDMA) last year, an FDA official said Monday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)